New mint on the block - Fresh hope for IBS treatment?

Radislav Nakov¹, Henriette Heinrich^{2

3}

Affiliations

¹ Clinic of Gastroenterology, Tsaritsa Yoanna University Hospital, Medical University of Sofia, Sofia, Bulgaria.
² St. Anna Spital, Luzern, Switzerland.
³ University of Zuerich, Zuerich, Switzerland.

Editorial

Radislav Nakov et al. United European Gastroenterol J. 2021 Nov.

. 2021 Nov;9(9):991-992.

doi: 10.1002/ueg2.12166. Epub 2021 Nov 3.

Radislav Nakov¹, Henriette Heinrich^{2

3}

¹ Clinic of Gastroenterology, Tsaritsa Yoanna University Hospital, Medical University of Sofia, Sofia, Bulgaria.
² St. Anna Spital, Luzern, Switzerland.
³ University of Zuerich, Zuerich, Switzerland.

No abstract available

Keywords: IBS; Irritable bowel syndrome; constipation; gastroenterology; motility.

Comment on

A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
Weerts ZZRM, Essers BAB, Jonkers DMAE, Willems JIA, Janssen DJPA, Witteman BJM, Clemens CHM, Westendorp A, Masclee AAM, Keszthelyi D. Weerts ZZRM, et al. United European Gastroenterol J. 2021 Nov;9(9):997-1006. doi: 10.1002/ueg2.12134. Epub 2021 Sep 1. United European Gastroenterol J. 2021. PMID: 34468079 Free PMC article. Clinical Trial.

1. Shah ED, Salwen‐Deremer JK, Gibson PR, Muir JG, Eswaran S, Chey WD. Comparing costs and outcomes of treatments for irritable bowel syndrome with diarrhea: cost‐benefit analysis. Clin Gastroenterol Hepatol. 2020. Oct 1;S1542‐3565(20):31373–2. Epub ahead of print. PMID: 33010413. - PubMed
1. Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, et al. Irritable bowel syndrome diagnosis and management: a simplified algorithm for clinical practice. United European Gastroenterol J. 2017;5(6):773–88. - PMC - PubMed
1. Flacco ME, Manzoli L, De Giorgio R, Gasbarrini A, Cicchetti A, Bravi F, et al. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta‐analysis. Eur Rev Med Pharmacol Sci. 2019. Apr;23(7):2986–3000. 10.26355/eurrev_201904_17580 - DOI - PubMed
1. Törnblom H, Goosey R, Wiseman G, Baker S, Emmanuel A. Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: results from patient and healthcare professional surveys. United European Gastroenterol J. 2018;6(9):1417–27. - PMC - PubMed
1. Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Alimentary pharmacology & therapeutics. 2018;47(6):738–52. - PMC - PubMed